XERI
Xeriant, Inc.Company with tickers: XERI
CIK
1481504
CUSIP
98422N103
Shares Outstanding
924,611,480
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $885,824 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Research & Development | $99,905 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Operating Income | $-885,824 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Net Income | $1,509,086 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| EPS (Basic) | $0.00 | USD/shares | 2026-03-31 | 10-Q | 2026-05-15 |
| EPS (Diluted) | $0.00 | USD/shares | 2026-03-31 | 10-Q | 2026-05-15 |